FindTrial
Sign In

The Comparison of Nanopore sequencing and Antimicrobial Susceptibility Standard Test in Diagnosis of Carbapenem-resistant Enterobacteriaceae in Urinary tract infection in King Chulalongkorn Memorial Hostpital

The Comparison of Nanopore sequencing and Antimicrobial Susceptibility Standard Test in Diagnosis of Carbapenem-resistant Enterobacteriaceae in Urinary tract infection in King Chulalongkorn Memorial Hostpital

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20200707002
Enrollment
70
Registered
2020-07-07
Start date
2020-07-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

select only one microbial if polymicrobial should be excluded

Interventions

UA WBC more than 5&#45
10 Urine gram shown gram negative rod
Diagnostic
Enterobacteriaceae UTI

Sponsors

Ratchadapisek Sompoch Fund
Lead Sponsor
Ratchadapisek Sompoch Fund
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age more than 18 years patient in KCMH 2. Enterobacteriaceae UTI

Exclusion criteria

Exclusion criteria: 1. small amount of urine specimen 2. small amount of DNA product 3. polymicrobial bacteria

Design outcomes

Primary

MeasureTime frame
Accuracy of agreement in drug resistance of Nanopore sequencing compare with conventional(CRE) 3 days agreement of antibacterial susceptibility—

Secondary

MeasureTime frame
Accuracy of agreement in drug resistance of Nanopore sequencing compare with conventional(ESBL)) 3days agreement—

Countries

Thailand

Contacts

Public ContactPannaporn Thongsuk

King Chulalongkorn Memorial Hospital

lunlanan_pnp@hotmail.com0993697770

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026